Trials / Completed
CompletedNCT00150371
Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration
A Multicenter, 12 Week Treatment Single Step Titration Open-Label Study Assessing The % Of Patients Achieving Ldl-C Target With Atorvastatin Starting Doses Of 10mg, 20mg, 40mg and 80mg.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,100 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 30 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the effectiveness of an atorvastatin treatment regimen involving starting doses between 10 and 80 mg, followed by a single-step titration (except for subjects started at 80mg), if required
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | atorvastatin |
Timeline
- Start date
- 2004-06-01
- Completion
- 2005-05-01
- First posted
- 2005-09-08
- Last updated
- 2021-02-18
Locations
84 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00150371. Inclusion in this directory is not an endorsement.